Markets:

Overview

News

Currencies

International

Treasuries

Lyell Immunopharma, Inc. - Common Stock (NQ:LYEL)

22.64 -1.54 (-6.37%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lyell Immunopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer

December 15, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday ↗

December 09, 2022

U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions ↗

October 25, 2022

Via Benzinga

Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock ↗

October 17, 2022

Via Benzinga

Lyell Immunopharma to Participate in BofA Securities Biotech Conference

December 01, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series

November 10, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results

November 08, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors

November 07, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference

November 02, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 25, 2022

Gainers

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

October 17, 2022

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 ↗

October 17, 2022

Upgrades

Via Benzinga

Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced with its Novel Epigenetic Reprogramming Technology for Solid Tumors

October 06, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 05, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer

September 28, 2022

From Lyell Immunopharma, Inc

Via GlobeNewswire

5 Value Stocks In The Healthcare Sector ↗

September 12, 2022

What are Value Stocks?

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 26, 2022

Via Benzinga

Why U.S. Stocks Are Trading Lower; AZZ Earnings And More ↗

July 11, 2022

U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.

Via Benzinga

Biotech ETF Tops in June: 5 Stocks That Outperform ↗

June 30, 2022

Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%.

Via Talk Markets

FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors ↗

January 24, 2022

The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors....

Via Benzinga

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗

December 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 05, 2022

Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

54 Biggest Movers From Friday ↗

October 04, 2021

Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 28, 2021

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.